NCODA and Florida Cancer Specialists & Research Institute jointly announced the development of a novel oncology stakeholder education exchange program.
Cazenovia, NY, August 16, 2022 – Florida Cancer Specialists & Research Institute (FCS) jointly announced with NCODA the development of a virtual learning platform that offers focused education for governance-level Board members, disease-state experts, and generalists.
FCS will be the first to utilize this new program, with the latest updates and detailed information to be made available in real-time at the user’s convenience on NCODA’s platform, Rxchange.
Lucio Gordan, MD, FCS chief medical officer for Therapeutics and Analytics, said, “organizing the education and information exchange between providers and other health care stakeholders has been long overdue. Rxchange will greatly enhance the 2-way flow of information in an environment of rapid and unprecedented developments in cancer care and help to enhance overall patient care.“
Mental Health Awareness: Transforming Workplace Support and Engagement
May 20th 2025Explore how employers enhance workplace mental health by fostering a culture of support and engagement, focusing on holistic well-being strategies in this interview with Jim Kinville, MA, University of Pittsburgh Medical Center.
Listen
Community Oncology Reacts to Trump's Drug Pricing Executive Order
May 2nd 2025An executive order signed on Tuesday, March 15, necessitated a change in plans for this panel discussion from the 2025 Community Oncology Conference, with the assembled experts, moderated by Ted Okon, MBA, executive director of the Community Oncology Alliance, speaking to how the order would reverberate across the community oncology space.
Read More